There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Also, Patheon opens new European headquarters, Cynvec appoints Frank D. Stonebanks president and CEO, more...

Company and People Notes: Amylin, A.P. Pharma, Avigen, and CombinatoRx Announce Staff Reductions; Maccine Appoints Leigh Berryman CEO; More...

PAT may reduce costs by helping companies control process variability, improve yields, reduce waste, and produce high-quality therapies consistently. Companies that have not yet embraced PAT may find its potential to reduce expenses a compelling argument in its favor during this time of financial difficulty.

A Propitious Period for PAT?

Until recently, automated inspection of solid-dose pharmaceuticals was crude, expensive, slow, and difficult to change over. But technological advances have ushered in a new class of vision-inspection systems that is more effective and more commercially viable than older systems.

Quality Is in the Eye of the Inspection System

Also, Sartorius Stedim Biotech GmbH to acquire Wave Biotech; AstraZeneca's John Patterson to retire; more...

Company and People Notes: GSK to Acquire Genelabs Technologies; Sigma-Aldrich Makes Personnel Announcements; More...

Brief pharmaceutical news items for November 2008.

Pharma Capsules

Stefan Schuber, PhD, is director of scientific affairs at the United States Pharmacopeial Convention.

Anthony DeStefano, PhD, is 2013 president of the American Association of Pharmaceutical Scientists (AAPS).

Roger L. Williams, MD, is executive vice-president and chief executive officer, USP

William F. Koch, PhD, is chief metrology officer, USP

Darrell R. Abernethy, MD, PhD, is chief science officer, all at the United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, MD 20852-1790, tel. 301.816.8184, dra@usp.org

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.

Inside USP: USP Metals Testing: A Workshop Report

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Pharma companies could benefit from the lessons learned in this fall's financial crisis.

Quality Counts

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Pharmaceutical Technology will feature video coverage of AAPS this month.

Bringing AAPS to You

Molecules called "chaperones" facilitate correct protein folding.

Coming Down the Pike: Chaperones

Diego Vargas is a senior engineer at Merck & Co.

Brian K. Meyer is a research fellow at Merck & Co., 770 Sumneytown Pike, West Point, PA 19486, tel. 215.652.3992, fax 215.652.5299.

The authors explain the factors that can cause a failure in a bubble-point integrity test and what to consider when a product-specific bubble point must be defined.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes